Financials
- Market Capitalization 22.82 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.41
Relación precio/flujo de caja
3.86
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 518 | ROIV Roivant Sciences Ltd. - Common Shares | 34.51 USD | -4.06% | -2.73% | +14.80% | +88.48% | 24.82 B USD | ||
| 535 | INSM Insmed Incorporated - Common Stock | 109.14 USD | -5.60% | -3.60% | +10.53% | -32.65% | 23.66 B USD | ||
| 557 | UTHR United Therapeutics Corporation - Common Stock | 535.57 USD | -2.10% | -4.20% | -1.90% | +79.90% | 22.73 B USD | ||
| 573 | BNTX BioNTech SE - American Depositary Shares | 90.07 USD | -1.55% | -4.60% | -1.25% | -18.86% | 21.61 B USD |